STRIDES PHARMA SCIENCE
|
STRIDES PHARMA SCIENCE Last 5 Year Income Statement History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Gross Sales | ₹7,068 Cr | ₹7,091 Cr | ₹6,089 Cr | ₹6,245 Cr | ₹5,327 Cr |
| Sales | ₹6,780 Cr | ₹6,870 Cr | ₹5,867 Cr | ₹6,100 Cr | ₹5,213 Cr |
| Job Work/ Contract Receipts | - | - | - | - | - |
| Processing Charges / Service Income | ₹1,202 Cr | ₹126 Cr | ₹129 Cr | ₹65 Cr | ₹66 Cr |
| Revenue from property development | - | - | - | - | - |
| Other Operational Income | ₹-914 Cr | ₹95 Cr | ₹93 Cr | ₹81 Cr | ₹48 Cr |
| Less: Excise Duty | - | - | - | - | - |
| Net Sales | ₹4,859 Cr | ₹4,565 Cr | ₹3,890 Cr | ₹3,688 Cr | ₹3,070 Cr |
| EXPENDITURE : | |||||
| Increase/Decrease in Stock | ₹38 Cr | ₹-184 Cr | ₹43 Cr | ₹-2.67 Cr | ₹95 Cr |
| Raw Material Consumed | ₹1,920 Cr | ₹2,164 Cr | ₹1,706 Cr | ₹1,630 Cr | ₹1,407 Cr |
| Opening Raw Materials | ₹416 Cr | ₹507 Cr | ₹522 Cr | ₹575 Cr | ₹552 Cr |
| Purchases Raw Materials | ₹1,819 Cr | ₹1,385 Cr | ₹1,136 Cr | ₹1,389 Cr | ₹1,114 Cr |
| Closing Raw Materials | ₹676 Cr | ₹416 Cr | ₹507 Cr | ₹522 Cr | ₹575 Cr |
| Other Direct Purchases / Brought in cost | ₹362 Cr | ₹688 Cr | ₹555 Cr | ₹188 Cr | ₹316 Cr |
| Other raw material cost | - | - | - | - | - |
| Power & Fuel Cost | ₹66 Cr | ₹58 Cr | ₹75 Cr | ₹86 Cr | ₹72 Cr |
| Electricity & Power | ₹66 Cr | ₹58 Cr | ₹75 Cr | ₹86 Cr | ₹72 Cr |
| Oil, Fuel & Natural gas | - | - | - | - | - |
| Coals etc | - | - | - | - | - |
| Other power & fuel | - | - | - | - | - |
| Employee Cost | ₹929 Cr | ₹863 Cr | ₹737 Cr | ₹732 Cr | ₹647 Cr |
| Salaries, Wages & Bonus | ₹772 Cr | ₹732 Cr | ₹623 Cr | ₹594 Cr | ₹528 Cr |
| Contributions to EPF & Pension Funds | ₹79 Cr | ₹61 Cr | ₹54 Cr | ₹60 Cr | ₹55 Cr |
| Workmen and Staff Welfare Expenses | ₹77 Cr | ₹68 Cr | ₹59 Cr | ₹76 Cr | ₹64 Cr |
| Other Employees Cost | ₹0.31 Cr | ₹1.61 Cr | ₹1.59 Cr | ₹1.30 Cr | ₹-0.71 Cr |
| Other Manufacturing Expenses | ₹403 Cr | ₹312 Cr | ₹300 Cr | ₹259 Cr | ₹256 Cr |
| Sub-contracted / Out sourced services | ₹116 Cr | ₹69 Cr | ₹53 Cr | ₹45 Cr | ₹48 Cr |
| Processing Charges | - | - | - | - | - |
| Repairs and Maintenance | ₹183 Cr | ₹149 Cr | ₹162 Cr | ₹131 Cr | ₹111 Cr |
| Packing Material Consumed | - | - | - | - | - |
| Other Mfg Exp | ₹104 Cr | ₹94 Cr | ₹85 Cr | ₹83 Cr | ₹96 Cr |
| General and Administration Expenses | ₹251 Cr | ₹222 Cr | ₹198 Cr | ₹232 Cr | ₹224 Cr |
| Rent , Rates & Taxes | ₹81 Cr | ₹73 Cr | ₹77 Cr | ₹67 Cr | ₹60 Cr |
| Insurance | ₹17 Cr | ₹20 Cr | ₹18 Cr | ₹26 Cr | ₹21 Cr |
| Printing and stationery | ₹2.67 Cr | ₹3.18 Cr | ₹3.36 Cr | ₹4.16 Cr | ₹3.61 Cr |
| Professional and legal fees | ₹114 Cr | ₹99 Cr | ₹76 Cr | ₹108 Cr | ₹119 Cr |
| Traveling and conveyance | ₹28 Cr | ₹20 Cr | ₹16 Cr | ₹14 Cr | ₹9.11 Cr |
| Other Administration | ₹8.39 Cr | ₹6.85 Cr | ₹7.44 Cr | ₹15 Cr | ₹12 Cr |
| Selling and Distribution Expenses | ₹357 Cr | ₹298 Cr | ₹215 Cr | ₹264 Cr | ₹331 Cr |
| Advertisement & Sales Promotion | ₹78 Cr | ₹54 Cr | ₹37 Cr | ₹22 Cr | ₹18 Cr |
| Sales Commissions & Incentives | ₹15 Cr | ₹10 Cr | ₹10 Cr | ₹17 Cr | ₹13 Cr |
| Freight and Forwarding | ₹264 Cr | ₹233 Cr | ₹168 Cr | ₹225 Cr | ₹301 Cr |
| Handling and Clearing Charges | - | - | - | - | - |
| Other Selling Expenses | - | - | - | - | - |
| Miscellaneous Expenses | ₹49 Cr | ₹35 Cr | ₹44 Cr | ₹103 Cr | ₹61 Cr |
| Bad debts /advances written off | - | - | - | - | - |
| Provision for doubtful debts | - | ₹1.09 Cr | ₹15 Cr | ₹34 Cr | - |
| Losson disposal of fixed assets(net) | - | - | - | - | - |
| Losson foreign exchange fluctuations | - | - | - | - | ₹9.78 Cr |
| Losson sale of non-trade current investments | - | - | - | - | - |
| Other Miscellaneous Expenses | ₹49 Cr | ₹34 Cr | ₹29 Cr | ₹69 Cr | ₹51 Cr |
| Less: Expenses Capitalised | - | - | - | - | - |
| Total Expenditure | ₹4,014 Cr | ₹3,768 Cr | ₹3,318 Cr | ₹3,303 Cr | ₹3,092 Cr |
| Operating Profit (Excl OI) | ₹845 Cr | ₹798 Cr | ₹572 Cr | ₹385 Cr | ₹-22 Cr |
| Other Income | ₹231 Cr | ₹64 Cr | ₹50 Cr | ₹135 Cr | ₹133 Cr |
| Interest Received | ₹27 Cr | ₹45 Cr | ₹30 Cr | ₹75 Cr | ₹107 Cr |
| Dividend Received | - | - | - | - | - |
| Profit on sale of Fixed Assets | ₹104 Cr | ₹4.10 Cr | ₹1.43 Cr | ₹4.11 Cr | ₹11 Cr |
| Profits on sale of Investments | ₹13 Cr | ₹2.63 Cr | ₹0.79 Cr | ₹0.02 Cr | ₹0.29 Cr |
| Provision Written Back | ₹6.32 Cr | - | ₹0.08 Cr | ₹0.84 Cr | ₹1.41 Cr |
| Foreign Exchange Gains | ₹74 Cr | ₹3.35 Cr | ₹9.64 Cr | ₹45 Cr | - |
| Others | ₹5.98 Cr | ₹8.32 Cr | ₹8.27 Cr | ₹11 Cr | ₹13 Cr |
| Operating Profit | ₹1,076 Cr | ₹862 Cr | ₹622 Cr | ₹521 Cr | ₹112 Cr |
| Interest | ₹179 Cr | ₹249 Cr | ₹280 Cr | ₹261 Cr | ₹177 Cr |
| InterestonDebenture / Bonds | - | - | - | - | - |
| Interest on Term Loan | ₹141 Cr | ₹198 Cr | ₹220 Cr | ₹198 Cr | ₹129 Cr |
| Intereston Fixed deposits | - | - | - | - | - |
| Bank Charges etc | ₹28 Cr | ₹41 Cr | ₹42 Cr | ₹44 Cr | ₹31 Cr |
| Other Interest | ₹9.43 Cr | ₹9.10 Cr | ₹18 Cr | ₹20 Cr | ₹17 Cr |
| PBDT | ₹897 Cr | ₹613 Cr | ₹342 Cr | ₹259 Cr | ₹-65 Cr |
| Depreciation | ₹202 Cr | ₹192 Cr | ₹214 Cr | ₹243 Cr | ₹233 Cr |
| Profit Before Taxation & Exceptional Items | ₹695 Cr | ₹420 Cr | ₹128 Cr | ₹16 Cr | ₹-298 Cr |
| Exceptional Income / Expenses | ₹-27 Cr | ₹65 Cr | ₹-189 Cr | ₹-17 Cr | ₹-244 Cr |
| Profit Before Tax | ₹669 Cr | ₹487 Cr | ₹-115 Cr | ₹-286 Cr | ₹-653 Cr |
| Provision for Tax | ₹94 Cr | ₹78 Cr | ₹29 Cr | ₹-55 Cr | ₹-178 Cr |
| Current Income Tax | ₹100 Cr | ₹60 Cr | ₹45 Cr | ₹20 Cr | ₹10 Cr |
| Deferred Tax | ₹22 Cr | ₹29 Cr | ₹-14 Cr | ₹-24 Cr | ₹-17 Cr |
| Other taxes | ₹-28 Cr | ₹-11 Cr | ₹-1.86 Cr | ₹-52 Cr | ₹-172 Cr |
| Profit After Tax | ₹575 Cr | ₹409 Cr | ₹-144 Cr | ₹-231 Cr | ₹-474 Cr |
| Extra items | - | ₹3,188 Cr | ₹50 Cr | ₹19 Cr | - |
| Minority Interest | ₹-18 Cr | ₹-4.06 Cr | ₹24 Cr | ₹9.70 Cr | ₹14 Cr |
| Share of Associate | - | - | - | - | - |
| Other Consolidated Items | - | - | - | - | - |
| Consolidated Net Profit | ₹556 Cr | ₹3,593 Cr | ₹-71 Cr | ₹-203 Cr | ₹-460 Cr |
| Adjustments to PAT | - | - | - | - | - |
| Profit Balance B/F | ₹459 Cr | ₹-284 Cr | ₹-200 Cr | ₹2.31 Cr | ₹485 Cr |
| Appropriations | ₹1,015 Cr | ₹3,309 Cr | ₹-271 Cr | ₹-200 Cr | ₹25 Cr |
| General Reserves | - | - | - | - | - |
| Proposed Equity Dividend | - | - | - | - | - |
| Corporate dividend tax | - | - | - | - | - |
| Other Appropriation | ₹37 Cr | ₹2,850 Cr | ₹14 Cr | - | ₹22 Cr |
| Equity Dividend % | ₹50.00 | ₹40.00 | ₹25.00 | ₹15.00 | - |
| Earnings Per Share | ₹60.34 | ₹389.90 | ₹-7.68 | ₹-22.44 | ₹-51.25 |
| Adjusted EPS | ₹60.34 | ₹389.90 | ₹-7.68 | ₹-22.44 | ₹-51.25 |
Compare Income Statement of peers of STRIDES PHARMA SCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| STRIDES PHARMA SCIENCE | ₹9,167.4 Cr | -0.1% | -7% | 22.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,271.0 Cr | -0.5% | -0.3% | 18.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,843.0 Cr | 3.1% | 18.9% | 33.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,000.0 Cr | -1.5% | -1.6% | 35.6% | Stock Analytics | |
| CIPLA | ₹118,072.0 Cr | -0.9% | 1.6% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,073.0 Cr | 2% | -3.8% | -0.7% | Stock Analytics | |
STRIDES PHARMA SCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| STRIDES PHARMA SCIENCE | -0.1% |
-7% |
22.2% |
| SENSEX | -0.8% |
0.5% |
-3.8% |
You may also like the below Video Courses